ANÁLISIS DE UN MODELO DE INNOVACIÓN TECNOLÓGICA DIRIGIDO AL SECTOR FARMACÉUTICO EN EL ECUADOR

Abstract

Ecuadorian pharmaceutical companies have increased in recent years , this due to the liberalization of drug patents held by multinational corporations. The benefits of the technology offered by the current globalization , could mean finding a competitive advantage for companies that want to differentiate themselves and stand out for the implementation of an innovation of this kind. Through surveys to managers of organizations in the pharmaceutical sector it is found that a low percentage of companies are considered innovative and that technological innovation is affected by the low risk tolerance of managers and the limited availability of equipment for obtaining and managing information relevant to innovation . It is therefore recommended to carry out actions to improve risk tolerance and errors generated in the attempt to innovate properly